| 000 | 01812 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517042646.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1421-9670 | ||
| 024 | 7 |
_a10.1159/000437001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDahlan, Randah | |
| 245 | 0 | 0 |
_aPrimary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011. _h[electronic resource] |
| 260 |
_bAmerican journal of nephrology _c2015 |
||
| 300 |
_a429-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xcomplications |
| 650 | 0 | 4 |
_aBacterial Infections _xcomplications |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemolytic-Uremic Syndrome _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aInternational Normalized Ratio |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aPartial Thromboplastin Time |
| 650 | 0 | 4 | _aPlasma Exchange |
| 650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xdiagnosis |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aReferral and Consultation |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aRituximab _xtherapeutic use |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSontrop, Jessica M | |
| 700 | 1 | _aLi, Lihua | |
| 700 | 1 | _aGhadieh, Omar | |
| 700 | 1 | _aClark, William F | |
| 773 | 0 |
_tAmerican journal of nephrology _gvol. 41 _gno. 6 _gp. 429-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000437001 _zAvailable from publisher's website |
| 999 |
_c25082423 _d25082423 |
||